2019年,国际个性化医疗联盟(ICPerMed)提出了一个愿景,即个性化医疗(PM)方法的使用将如何在2030年促进“下一代”医学更加坚定地围绕个人的个人特征。通过研究,在可持续的医疗保健系统中改善健康结果,发展,创新,为了病人的利益,公民,和社会。然而,医疗保健专业人员有很大的障碍,研究人员,政策制定者,患者必须克服实施PM。ICPerMed旨在提供建议,以提高利益相关者对为实现PM而实施的可行措施的认识。从PM的最佳实践示例以及专家和利益相关者的咨询开始,仔细分析强调了障碍,机遇,recommendations,和信息,旨在开发有关医疗保健实践中PM实施要求的知识,已提供。已经为PM集成到医疗保健系统定义了实用的路线图,建议采取行动克服现有障碍,并利用PM改善健康结果的潜力。事实上,为了促进不同利益相关者采用PM,必须有一套全面的资源,以满足PM关键领域的利益相关者的需求。这些包括参与战略,协作框架,基础设施建设,教育和培训计划,伦理考虑,资源分配准则,法规遵从性,数据管理和隐私。
In 2019, the International Consortium for Personalised Medicine (ICPerMed) developed a vision on how the use of personalized medicine (PM) approaches will promote \"next-generation\" medicine in 2030 more firmly centered on the individual\'s personal characteristics, leading to improved health outcomes within sustainable healthcare systems through research, development, innovation, and implementation for the benefit of patients, citizens, and society. Nevertheless, there are significant hurdles that healthcare professionals, researchers, policy makers, and patients must overcome to implement PM. The ICPerMed aims to provide recommendations to increase stakeholders\' awareness on actionable measures to be implemented for the realization of PM. Starting with best practice examples of PM together with consultation of experts and stakeholders, a careful analysis that underlined hurdles, opportunities, recommendations, and information, aiming at developing knowledge on the requirements for PM implementation in healthcare practices, has been provided. A pragmatic roadmap has been defined for PM integration into healthcare systems, suggesting actions to overcome existing barriers and harness the potential of PM for improved health outcomes. In fact, to facilitate the adoption of PM by diverse stakeholders, it is mandatory to have a comprehensive set of resources tailored to stakeholder needs in critical areas of PM. These include engagement strategies, collaboration frameworks, infrastructure development, education and training programs, ethical considerations, resource allocation guidelines, regulatory compliance, and data management and privacy.